Key result
The A400V mutation rendered full-length wild-type myosin almost completely inactive, while the reverse V400A mutation in the cardiac CM-loop chimera restored almost full activity.
Mutations in the cardiomyopathy loop of myosin II, including those analogous to human hypertrophic cardiomyopathy mutations, significantly alter biochemical kinetics and biological function in a Dictyostelium model.
Answers are grounded in this paper and cite their sources.
Dictyostelium model data on CM-loop mutations; hypothesis-generating for HCM mechanisms, should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2005) studied Familial hypertrophic cardiomyopathy (contextual). Mutations of the Cardiomyopathy Loop of Dictyostelium Myosin II vs. Wild-type myosin was evaluated on Biological functions (growth, capping, development) and biochemical activities (actin-activated MgATPase, in vitro motility). The A400V mutation rendered full-length wild-type myosin almost completely inactive, while the reverse V400A mutation in the cardiac CM-loop chimera restored almost full activity.
Synapse has enriched 10 related papers. Consider them for comparative context: